UiPath Inc. (NYSE:PATH) Shares Bought by Balentine LLC

Balentine LLC grew its holdings in shares of UiPath Inc. (NYSE:PATH) by 6.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,553 shares of the healthcare company’s stock after purchasing an additional 889 shares during the period. Balentine LLC’s holdings in UiPath were worth $386,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Royal London Asset Management Ltd. lifted its position in UiPath by 5.9% in the 3rd quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company’s stock valued at $2,388,000 after purchasing an additional 7,742 shares during the last quarter. Swiss National Bank lifted its position in UiPath by 4.9% in the 4th quarter. Swiss National Bank now owns 1,211,500 shares of the healthcare company’s stock valued at $30,094,000 after purchasing an additional 56,600 shares during the last quarter. Vestmark Advisory Solutions Inc. bought a new stake in UiPath in the 4th quarter valued at about $15,543,000. O Shaughnessy Asset Management LLC bought a new stake in UiPath in the 3rd quarter valued at about $203,000. Finally, Invesco Ltd. lifted its position in UiPath by 2.8% in the 3rd quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company’s stock valued at $6,830,000 after purchasing an additional 10,863 shares during the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Price Performance

UiPath stock opened at $19.90 on Wednesday. The firm’s 50 day simple moving average is $20.88 and its 200-day simple moving average is $22.09. UiPath Inc. has a fifty-two week low of $13.30 and a fifty-two week high of $27.87.

UiPath (NYSE:PATH) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, analysts forecast that UiPath Inc. will post -0.04 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on PATH shares. Canaccord Genuity Group lifted their price objective on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, March 15th. TD Cowen raised their target price on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, March 14th. Royal Bank of Canada reissued a “sector perform” rating and set a $29.00 target price on shares of UiPath in a research note on Monday, April 1st. Scotiabank raised their target price on shares of UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a research note on Thursday, March 14th. Finally, Morgan Stanley raised their target price on shares of UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, UiPath currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.41.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the sale, the chief financial officer now directly owns 87,505 shares in the company, valued at $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold a total of 96,000 shares of company stock valued at $2,023,440 over the last ninety days. Corporate insiders own 22.37% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.